Literature DB >> 15655674

MLPA analysis for the detection of deletions, duplications and complex rearrangements in the dystrophin gene: potential and pitfalls.

B Janssen1, C Hartmann, V Scholz, A Jauch, J Zschocke.   

Abstract

Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD) are common X-chromosomal recessive disorders caused by mutations in the dystrophin gene. Using the novel multiplex ligation-dependent probe amplification (MLPA) method we performed retrospective and prospective analyses in a total of 193 individuals. Deletions or duplications were identified in 14 out of 90 families previously tested negative by multiplex PCR or FISH analysis. Partially incorrect results were subsequently identified in two families: the loss of exon 38 signal in one case was due to a p.Q1802X nonsense mutation, whilst in another patient an apparent deletion of exon 37 (coinciding with a duplication of exons 46-53) was caused by a p.R1735C polymorphism. In one case we found a complex rearrangement involving a duplication of two regions: dupEX45-48 and dupEX54-55. We conclude that MLPA is a highly sensitive and rapid alternative to multiplex PCR. It can be used on blood samples, chorionic villi and paraffin-embedded tissue. The ease of detection of duplications and the application for female carrier analysis are clearly the main advantages of the method. However, apparent single exon deletions detected by MLPA should be checked by an independent method. Complex rearrangements such as double mutations on the same allele are rare.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15655674     DOI: 10.1007/s10048-004-0204-1

Source DB:  PubMed          Journal:  Neurogenetics        ISSN: 1364-6745            Impact factor:   2.660


  15 in total

1.  Measurement of locus copy number by hybridisation with amplifiable probes.

Authors:  J A Armour; C Sismani; P C Patsalis; G Cross
Journal:  Nucleic Acids Res       Date:  2000-01-15       Impact factor: 16.971

2.  Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification.

Authors:  Jan P Schouten; Cathal J McElgunn; Raymond Waaijer; Danny Zwijnenburg; Filip Diepvens; Gerard Pals
Journal:  Nucleic Acids Res       Date:  2002-06-15       Impact factor: 16.971

3.  Two distinct mutations in a single dystrophin gene: chance occurrence or premutation?

Authors:  N G Laing; M G Layton; R D Johnsen; D C Chandler; M E Mears; J Goldblatt; B A Kakulas
Journal:  Am J Med Genet       Date:  1992-03-01

4.  Topography of the Duchenne muscular dystrophy (DMD) gene: FIGE and cDNA analysis of 194 cases reveals 115 deletions and 13 duplications.

Authors:  J T Den Dunnen; P M Grootscholten; E Bakker; L A Blonden; H B Ginjaar; M C Wapenaar; H M van Paassen; C van Broeckhoven; P L Pearson; G J van Ommen
Journal:  Am J Hum Genet       Date:  1989-12       Impact factor: 11.025

5.  Direct carrier detection by in situ suppression hybridization with cosmid clones of the Duchenne/Becker muscular dystrophy locus.

Authors:  T Ried; V Mahler; P Vogt; L Blonden; G J van Ommen; T Cremer; M Cremer
Journal:  Hum Genet       Date:  1990-10       Impact factor: 4.132

6.  Restoration of half the normal dystrophin sequence in a double-deletion Duchenne muscular dystrophy family.

Authors:  R C Hoop; L S Russo; D L Riconda; L S Schwartz; E P Hoffman
Journal:  Am J Med Genet       Date:  1994-02-01

7.  Accurate diagnosis of carriers of deletions and duplications in Duchenne/Becker muscular dystrophy by fluorescent dosage analysis.

Authors:  S C Yau; M Bobrow; C G Mathew; S J Abbs
Journal:  J Med Genet       Date:  1996-07       Impact factor: 6.318

8.  Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals.

Authors:  M Koenig; E P Hoffman; C J Bertelson; A P Monaco; C Feener; L M Kunkel
Journal:  Cell       Date:  1987-07-31       Impact factor: 41.582

9.  Somatic mosaicism for a deletion of the dystrophin gene in a carrier of Becker muscular dystrophy.

Authors:  T Voit; E Neuen-Jacob; V Mahler; A Jauch; M Cremer
Journal:  Eur J Pediatr       Date:  1992-02       Impact factor: 3.183

10.  Deletion screening of the Duchenne muscular dystrophy locus via multiplex DNA amplification.

Authors:  J S Chamberlain; R A Gibbs; J E Ranier; P N Nguyen; C T Caskey
Journal:  Nucleic Acids Res       Date:  1988-12-09       Impact factor: 16.971

View more
  38 in total

1.  Measurement of the clinical utility of a combined mutation detection protocol in carriers of Duchenne and Becker muscular dystrophy.

Authors:  Peter J Taylor; Sarah Maroulis; Glenda L Mullan; Robyn L Pedersen; Aurora Baumli; George Elakis; Sara Piras; Corrina Walsh; Benito Prósper-Gutiérrez; Fernando De La Puente-Alonso; Christopher G Bell; David R Mowat; Heather M Johnston; Michael F Buckley
Journal:  J Med Genet       Date:  2007-01-26       Impact factor: 6.318

2.  Clinical Utility Gene Card for: Becker muscular dystrophy.

Authors:  David Coote; Mark R Davis; Macarena Cabrera; Merrilee Needham; Nigel G Laing; Kristen J Nowak
Journal:  Eur J Hum Genet       Date:  2018-02-21       Impact factor: 4.246

Review 3.  Genetic diagnosis as a tool for personalized treatment of Duchenne muscular dystrophy.

Authors:  Luca Bello; Elena Pegoraro
Journal:  Acta Myol       Date:  2016-12

4.  MLPA Application in Clinical Diagnosis of DMD/BMD in Shanghai.

Authors:  Xing Ji; Jingmin Zhang; Yan Xu; Fei Long; Wei Sun; Xiaoqin Liu; Yingwei Chen; Wenting Jiang
Journal:  J Clin Lab Anal       Date:  2014-08-17       Impact factor: 2.352

5.  Microarray-based mutation detection in the dystrophin gene.

Authors:  Madhuri R Hegde; Ephrem L H Chin; Jennifer G Mulle; David T Okou; Stephen T Warren; Michael E Zwick
Journal:  Hum Mutat       Date:  2008-09       Impact factor: 4.878

6.  Genetic variation of the Fc gamma receptor 3B gene and association with rheumatoid arthritis.

Authors:  Rute B Marques; Mohamed M Thabet; Stefan J White; Jeanine J Houwing-Duistermaat; Aleida M Bakker; Gert-Jan Hendriks; Alexandra Zhernakova; Tom W Huizinga; Annette H van der Helm-van Mil; Rene E Toes
Journal:  PLoS One       Date:  2010-10-05       Impact factor: 3.240

7.  Mutational spectrum of DMD mutations in dystrophinopathy patients: application of modern diagnostic techniques to a large cohort.

Authors:  Kevin M Flanigan; Diane M Dunn; Andrew von Niederhausern; Payam Soltanzadeh; Eduard Gappmaier; Michael T Howard; Jacinda B Sampson; Jerry R Mendell; Cheryl Wall; Wendy M King; Alan Pestronk; Julaine M Florence; Anne M Connolly; Katherine D Mathews; Carrie M Stephan; Karla S Laubenthal; Brenda L Wong; Paula J Morehart; Amy Meyer; Richard S Finkel; Carsten G Bonnemann; Livija Medne; John W Day; Joline C Dalton; Marcia K Margolis; Veronica J Hinton; Robert B Weiss
Journal:  Hum Mutat       Date:  2009-12       Impact factor: 4.878

8.  Identification of a heterozygous genomic deletion in the spatacsin gene in SPG11 patients using high-resolution comparative genomic hybridization.

Authors:  Peter Bauer; Beate Winner; Rebecca Schüle; Claudia Bauer; Veronika Häfele; Ute Hehr; Michael Bonin; Michael Walter; Kathrin Karle; Thomas M Ringer; Olaf Riess; Jürgen Winkler; Ludger Schöls
Journal:  Neurogenetics       Date:  2008-09-12       Impact factor: 2.660

9.  Tandem duplications of two separate fragments of the dystrophin gene in a patient with Duchenne muscular dystrophy.

Authors:  Zhujun Zhang; Yasuhiro Takeshima; Hiroyuki Awano; Atsushi Nishiyama; Yo Okizuka; Mariko Yagi; Masafumi Matsuo
Journal:  J Hum Genet       Date:  2007-12-27       Impact factor: 3.172

10.  Next-generation sequencing discloses a nonsense mutation in the dystrophin gene from long preserved dried umbilical cord and low-level somatic mosaicism in the proband mother.

Authors:  Mariko Taniguchi-Ikeda; Yasuhiro Takeshima; Tomoko Lee; Masahiro Nishiyama; Hiroyuki Awano; Mariko Yagi; Ai Unzaki; Kandai Nozu; Hisahide Nishio; Masafumi Matsuo; Hiroki Kurahashi; Tatsushi Toda; Ichiro Morioka; Kazumoto Iijima
Journal:  J Hum Genet       Date:  2016-01-07       Impact factor: 3.172

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.